Pages

Tuesday, January 1, 2013

New Year, New Weight Loss Pills? Microencapsulated Conjugated Linoleic Acid (CLA) Works in Humans! So Well, In fact, That Subjects Lost Weight Too Fast, But...

Posted by Unknown at 11:36 PM
Is microencapsulation like calling the artist him hammer away all the blubber? Hmm... maybe that's why it took Michelangelo > 3 years to complete his David. All jokes aside, is this encapsulation business really worth it or do you still have to sculpt your physique the good old way: Diet & Exercise?
If you look at the research, but even more the patents that were filed last year, you will realize the 2010s (looks awkward, right?) could become the decade of microencapsulation. Curcumin, green tea, vitamin C, scientists have and still are playing around with everything ME or NE... "ME or NE?" Yeah, right. Meanwhile it's actually so common that you often see only the acronym ME for microencapsulated and NE for nanoencapsulated in front of a supplement , extract or drug and know: They did it again.

In the case of conjugated linoleic acid (CLA), this is at least to my knowledge the first time that scientists used microencapsulation in order to make what appeared to become the big next thing in diet and weightloss pills - hold on, "next big thing" would imply that there had actually been "a big thing" and that's certainly not the case - at least nothing FDA compliant, let alone the Ally's and other junk from the pharmocracy.

New Year + New Technology + New Diet Pills = New, Leaner You?

Be that as it may, the study a group of Brazilian scientists has just published in Vascular Health and Risk Management does offer some hope, at least for those of the chronically overweight who are willing to use a weight loss supplement, exactly as the name implies, as a supplement that's taken on top of a calorically reduced and not just a "If I don't eat X,Y and Z - Quack A told me I can eat as much as I want and will still lose weight" diet. If you read the scientists research hypothesis, you will probably be surprised that they did actually expect that
"[...] microencapsulated CLA supplementation would improve glucose metabolism, the
serum lipid profile, and body composition, and decrease other cardiovascular risk factors associated with the metabolic syndrome." (Carvalho. 2012)
I mean, we all know that one of the problems with CLA - even in those mouse and few rodent trials, where it appeared to work - was actually that it lead to increases in liver fat, beginning fatty liver and consequent insulin resistance, right?

The addition of DHA to CLA  (as grass-fed butter has it) ameliorates the negative effects (read more). If you stick to the original  racemic mix of 9-cis trans-11 and trans-10, cis-12 isomers it may yet not even be necessary to protect your liver and insulin tolerance.
You will certainly remember the last study on the matter, where I speculated that the combination of DHA (not complete fish oil) and CLA a group of researchers led by Dawn M. Fedor had used to get only the beneficial, yet not the negative side effects in rodents, could actually hold the key to save and effective CLA supplementation in humans, as well (read more here). Now, with this study using a racemic, i.e. a 50:50 mixture of the naturally occuring CLA isomers 9-cis trans-11 and trans-10, cis-12 in humans and, as you are going to see in figure with nothing but beneficial effects on insulin sensitivity and glucose management, the question arises, whether you don't do best just eating more butter from grassfed cows.... ah, I am of course joking, I mean butter will clog your atheries, right? *rofl*

No, what I actually wanted to say was: If you look at the data in figure 2 & 3, there are 3 things I want you to keep in mind:
  1. The sedentary, nonsmoking, nondiabetic, not post-menopausal, not having a previous hypocaloric diet, and not taking dietary supplements or any medication to reduce body weight (read up on "Long term dieting makes you fat and insulin resistant") were on a diet with a caloric deficit designed to have them lose 2kg per of body weight per month. That's pretty reasonable, but still a major difference to just popping a pill and waiting for the body fat to fall off (look at how successful the diet alone was!)
  2. Figure 1: Long diets need adjustments in caloric intake (Carvalho. 2012)
    The whole study lasted 3 months! And it was necessary to readjust the energy intake after 60 days to 1976.8 ± 67.31 kcal, in the CLA group, and 1745.5 ± 118.20 kcal, in the placebo group to keep the weight loss "stable" - check out figure 1 and you know why I put quotationmarks before the word "stable". Also take into consideration that the CLA group ate more mostly because they had already overshot as far as their 2kg per month weight loss goal was concerned.
  3. The women would have had tremendously more success if they this study had had an exercise component, as well. With an energy expenditure of 22.27kcal/day and 23.35kcal/day from their usual "physical activity" - they could as well have been lying on the couch. Not that it was important or even smart to burn as many calories as possible, but ~23kcal is what most of you burn in 3-4 minutes of leisurely jogging or even brisk walking.
All that said: This is certainly not an optimal protocol and it cannot be said, whether the negative effects on glucose control would not have been evident if it was not for the game-changing caloric deficit (1). What has to be said in favor of the microencapsulated CLA (ME-CLA), though, is that it did not just come "side effect free", but had the exact opposite effect of what scientists still fear, namely the induction of insulin resistance.
Figure 2: Changes in parameters of blood glucose and lipid management (Carvalho. 2012)
That said, with a dosage for 3g of ME-CLA in *yummy* strawberry jam (sugar reduced *rofl*) per day, the absolute dosage was obviously lower than in most rodent studies and the usage of the racemic mixture could as well an important role in terms of the observed beneficial effects on blood glucose management. After all, previous studies have shown that cis-9,trans-11-octadecadienoate isomer is more potent than fish oil in improving lipid atherogenic risk markers (Valeille. 2004), does not share the pro-triglyceride and pro-insulin resistance effects of its brother and is probably also the anti-cancer isomer in CLA (Churruca. 2009). Unfortunately taken on it's own it does do little for weight or fat loss.
Figure 3: Effects of 3 months supplementation with 3g of microencapsulated CLA on body morphology (Carvalho. 2012)
Apropos, if you take a look at the data in figure 3 you will have to admit that the benefits were there, but compared to the health benefits, the weight loss benefits appear to be rather mediocre. And who telly me that the liver weight of the subjects did not still increase... well, it may not have been measured, but is overall very unlikely, 'cause that usually entails decreases and not improvements in blood glucose and lipid management.

Bottom line: Without a regular CLA control group this study tells us essentially nothing about the potency of microencapsulated conjugated linolic acid. After all, there are other human studies (also in obese individuals, also on a diet) reporting similar benefits with regular CLA (btw. in 99% of the cases also racemic mixtures). If anything the study confirms that in it's natural form, which is not an isolate of the fat burning and in high doses even fat annihilating (read more) trans-10, cis-12 CLA, is save probably healthy, but it is no magic anti-obesity pill (let alone something you take today and wake up ripped to the shreds tomorrow).

Another argument against the necessity of "functional" (?) CLA products, like ME-CLA jam, is the previous study showing that ~1.5g of CLA and vaccenic acid from dairy, beef, veal and lamp could prevent the subtle weight we all tend to ignore until it's already to late (read more)
Moreover, I suspect this will go for nano-encapsulated CLA (I bet a "market oriented" researcher has it already in development), as well, because encapsulation is something you want to do with stuff like curcumin, that won't even get where you want it, if you don't at least mess up your liver with some piperine so that it will let it pass unmetabolized. That's however not an issue with CLA, as the supplementation has proven time and again to increase CLA in serum and even tissue readily - even a higher intake of milk fat, which brings us back full circle to the image of the Kerrygold butter at the top, has been found to correlate significantly with higher levels of CLA in serum and adipose tissue (Jiang. 1999). So, if you see some strawberry jam with microencapsulated CLA in it on the shelves of your local supermarket in the course of 2013, you know that it's overpriced sugar... a pardon me, functional food with a reduced sugar content ;-)

On a different note: Thanks for all the good wishes and the appreciation you expressed in the comments. The did not go unnoticed! Hope all of you are more or less sober again, today, and in case you are not - don't forget the "Bismarck Herring" ;-)

References:
  • Carvalho RF, Uehara SK, Rosa G. Microencapsulated conjugated linoleic acid associated with hypocaloric diet reduces body fat in sedentary women with metabolic syndrome. Vasc Health Risk Manag. 2012;8:661-7. doi: 10.2147/VHRM.S37385. Epub 2012 Dec 13.
  • Churruca I, Fernández-Quintela A, Portillo MP. Conjugated linoleic acid isomers: differences in metabolism and biological effects. Biofactors. 2009 Jan-Feb;35(1):105-11.
  • Valeille K, Gripois D, Blouquit MF, Souidi M, Riottot M, Bouthegourd JC, Sérougne C, Martin JC. Lipid atherogenic risk markers can be more favourably influenced by the cis-9,trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters. Br J Nutr. 2004 Feb;91(2):191-9.

0 comments:

Post a Comment